Treatments for diabetic neuropathy

Area of Science:

• Neurology
• Endocrinology
• Pain Management

Background:

• Diabetic neuropathy affects diabetes patients, presenting as focal or diffuse peripheral nerve disorders.
• Focal neuropathies often resolve spontaneously with supportive care.
• Diabetic sensorimotor polyneuropathy (DSP) is the most common type, with limited disease-modifying treatments beyond glycemic control.

Purpose of the Study:

• To summarize current understanding and treatment options for diabetic neuropathy, focusing on painful DSP.
• To highlight evidence-based treatments for symptomatic relief in DSP.

Main Methods:

• Review of an evidence-based guideline on painful DSP treatment.
• Identification of pharmacological and non-pharmacological interventions.

Main Results:

• Optimal glycemic control, lifestyle, and risk factor modification are foundational.
• Effective treatments for painful DSP include pregabalin, amitriptyline, duloxetine, venlafaxine, gabapentin, opioids, nitrate sprays, capsaicin, and TENS.
• Treatment selection is individualized based on patient status.

Conclusions:

• While disease-modifying treatments for DSP are limited, symptomatic management is effective.
• A range of pharmacologic and non-pharmacologic options are available for painful DSP.
• Individualized treatment plans are crucial for managing painful DSP in diabetic patients.